HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recombinant vesicular stomatitis virus expressing influenza nucleoprotein induces CD8 T-cell responses that enhance antibody-mediated protection after lethal challenge with influenza virus.

Abstract
Live attenuated vaccine vectors based on recombinant vesicular stomatitis viruses (rVSVs) expressing foreign antigens are highly effective vaccines in animal models. In this study, we report that an rVSV expressing influenza nucleoprotein (VSV NP) from the first position of the VSV genome induces robust anti-NP CD8 T cells in immunized mice. These CD8 T cells are phenotypically similar to those induced by natural influenza infection and are cytotoxic in vivo. Animals immunized with an rVSV expressing the influenza hemagglutinin (rVSV HA) were protected but still exhibited considerable morbidity after challenge. Animals receiving a cocktail vaccine of rVSV NP and rVSV HA had reduced pulmonary viral loads, less weight loss, and reduced clinical signs of illness after influenza virus challenge, relative to those vaccinated with rVSV HA alone. Influenza NP is a highly conserved antigen, and induction of protective anti-NP responses may be a productive strategy for generating heterologous protection against divergent influenza strains.
AuthorsBrice E Barefoot, Christopher J Sample, Elizabeth A Ramsburg
JournalClinical and vaccine immunology : CVI (Clin Vaccine Immunol) Vol. 16 Issue 4 Pg. 488-98 (Apr 2009) ISSN: 1556-679X [Electronic] United States
PMID19244472 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Antibodies, Viral
  • Hemagglutinin Glycoproteins, Influenza Virus
  • Influenza Vaccines
  • NP protein, Influenza A virus
  • Nucleocapsid Proteins
  • RNA-Binding Proteins
  • Viral Core Proteins
Topics
  • Animals
  • Antibodies, Viral (immunology)
  • Body Weight
  • CD8-Positive T-Lymphocytes (immunology)
  • Female
  • Genetic Vectors
  • Hemagglutinin Glycoproteins, Influenza Virus (genetics, immunology)
  • Influenza Vaccines (genetics, immunology)
  • Lung (virology)
  • Mice
  • Nucleocapsid Proteins
  • Orthomyxoviridae Infections (pathology, prevention & control)
  • RNA-Binding Proteins (genetics, immunology)
  • Survival Analysis
  • Vesiculovirus (genetics)
  • Viral Core Proteins (genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: